Page last updated: 2024-10-22
alendronate and Health Care Associated Infection
alendronate has been researched along with Health Care Associated Infection in 1 studies
alendronic acid : A 1,1-bis(phosphonic acid) that is methanebis(phosphonic acid) in which the two methylene hydrogens are replaced by hydroxy and 3-aminopropyl groups.
Research Excerpts
| Excerpt | Relevance | Reference |
|---|
| " Alendronate treatment increases bone mass and reduces the risk of fractures in patients with osteoporosis by suppressing bone resorption." | 3.85 | Risk of long-term infection-related death in clinical osteoporotic vertebral fractures: A hospital-based analysis. ( Chen, YC; Lin, WC, 2017) |
Research
Studies (1)
| Timeframe | Studies, this research(%) | All Research% |
|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
Authors
| Authors | Studies |
|---|
| Chen, YC | 1 |
| Lin, WC | 1 |
Clinical Trials (1)
Trial Overview
| Trial | Phase | Enrollment | Study Type | Start Date | Status |
|---|
| Orthopaedic Conservative Treatment in the Time of Covid-19 Pandemic[NCT04623346] | | 262 participants (Anticipated) | Observational | 2020-03-11 | Active, not recruiting |
| [information is prepared from clinicaltrials.gov, extracted Sep-2024] |
Other Studies
1 other study available for alendronate and Health Care Associated Infection